Cargando…

Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease

BACKGROUND: Fibroblast growth factor 21 increased in population with type 2 diabetes mellitus (T2DM), while serum total testosterone often decreased in men with T2DM. This study aimed to investigate the relationship between the prevalence of coronary artery disease (CAD) and circulating FGF21 concen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Yufeng, Lyu, Yongnan, Zhao, Zhiming, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334747/ https://www.ncbi.nlm.nih.gov/pubmed/35909513 http://dx.doi.org/10.3389/fendo.2022.912243

Ejemplares similares

Circulating growth differentiation factor 15 levels and apolipoprotein B to apolipoprotein A1 ratio in coronary artery disease patients with type 2 diabetes mellitus
por: Mei, Yufeng, et al.
Publicado: (2022)

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
por: Xiao, Mengjie, et al.
Publicado: (2021)

Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus
por: Zhang, Xinxin, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2022)

Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

SAT-046 Insulin-Like Growth Factor and Fibroblast Growth Factor 21 in Men with Klinefelter Syndrome
por: Chang, Simon, et al.
Publicado: (2020)

PMON257 Oral Ingestion of Macronutrients Selectively and Variably Decrease Circulating Testosterone Concentration in Healthy Men
por: Iranmanesh, Ali, et al.
Publicado: (2022)

Relationship Between Serum Testosterone Levels and Kidney Stones Prevalence in Men
por: Huang, Fang, et al.
Publicado: (2022)

Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus
por: Toloza, Freddy J. K., et al.
Publicado: (2018)

Testosterone Increases Circulating Dehydroepiandrosterone Sulfate Levels in the Male Rhesus Macaque
por: Sorwell, Krystina G., et al.
Publicado: (2014)

Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
por: Zhang, Jun, et al.
Publicado: (2015)

Total Testosterone Confounds the Association Between Total Bilirubin and Dyslipidemia
por: Visaria, Aayush, et al.
Publicado: (2021)

Obstructive Sleep Apnea Is Associated With Low Testosterone Levels in Severely Obese Men
por: Tančić-Gajić, Milina, et al.
Publicado: (2021)

Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth
por: Yang, Meng-Nan, et al.
Publicado: (2022)

PMON267 Comparison Between Single Time Point Testing and 24-Hour Average Concentration of Total Testosterone in Hypogonadal Men Treated with an Oral Testosterone Undecanoate Softgel (JATENZO®)
por: Swerdloff, Ronald, et al.
Publicado: (2022)

Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes
por: Hu, Jingyi, et al.
Publicado: (2020)

Lowered Serum Testosterone Concentration Is Associated With Enhanced Inflammation and Worsened Lipid Profile in Men
por: Grandys, Marcin, et al.
Publicado: (2021)

Adapting to the Cold: A Role for Endogenous Fibroblast Growth Factor 21 in Thermoregulation?
por: Klein Hazebroek, Marlou, et al.
Publicado: (2020)

Correlation Between Gut Microbiota and Testosterone in Male Patients With Type 2 Diabetes Mellitus
por: Liu, Shuang, et al.
Publicado: (2022)

Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
por: Lee, Chi Ho, et al.
Publicado: (2017)

SAT-045 Free Testosterone and Cardiometabolic Parameters in Adult Men - Comparison of Algorithms for Calculation of Serum Free Testosterone
por: Holmboe, Stine Agergaard, et al.
Publicado: (2020)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

Effects of bariatric surgery on testosterone level and sexual function in men with obesity: A retrospective study
por: Chen, Guoji, et al.
Publicado: (2023)

UGT2B17 Genotype and the Pharmacokinetic Serum Profile of Testosterone during Substitution Therapy with Testosterone Undecanoate. A Retrospective Experience from 207 Men with Hypogonadism
por: Bang, Anne Kirstine, et al.
Publicado: (2013)

Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease
por: Liu, Huan, et al.
Publicado: (2019)

Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
por: Antonellis, Patrick Joseph, et al.
Publicado: (2016)

Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis
por: Yan, Bing, et al.
Publicado: (2023)

Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin
por: Cai, Tingting, et al.
Publicado: (2021)

Direct and indirect effects of fibroblast growth factor 23 on the heart
por: Nakano, Toshiaki, et al.
Publicado: (2023)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
por: Deepika, FNU, et al.
Publicado: (2022)

Changes in Men’s Salivary Testosterone and Cortisol Levels, and in Sexual Desire after Smelling Female Axillary and Vulvar Scents
por: Cerda-Molina, Ana Lilia, et al.
Publicado: (2013)

Oral administration of VDAC1-derived small molecule peptides increases circulating testosterone levels in male rats
por: Martinez–Arguelles, Daniel B., et al.
Publicado: (2023)

Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients
por: Xiao, Fangsen, et al.
Publicado: (2019)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
por: Traish, A M, et al.
Publicado: (2014)

Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023)

Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials
por: Tao, Jianping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hl15um3672b03cc4popdjpckrv